Malakoplakia after renal transplantation in the current era of immunosuppressive therapy: case report and literature review

被引:26
作者
Leao, C. A.
Duarte, M. I. S. [2 ]
Gamba, C.
Ramos, J. F.
Rossi, F. [3 ]
Galvao, M. M. [4 ]
David-Neto, E. [4 ]
Nahas, W. [4 ]
Shikanai-Yasuda, M. A.
Pierrotti, L. C. [1 ]
机构
[1] Univ Sao Paulo, Inst Cent, Infect Immunocompromised Hosts Grp, Hosp Clin,Sch Med, BR-05403900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Dept Pathol, BR-05403900 Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med, Microbiol Lab, Hosp Clin, BR-05403900 Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Med, Hosp Clin, Renal Transplantat Unit,Urol Div, BR-05403900 Sao Paulo, Brazil
关键词
malakoplakia; malacoplakia; renal transplantation; immunosuppression; tacrolimus; mycophenolate; Burkholderia cepacia; CUTANEOUS MALACOPLAKIA; MALAKOPLAKIA; RECIPIENTS; DRUGS;
D O I
10.1111/tid.12012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Malakoplakia is a rare chronic granulomatous disease of unknown cause. It is thought to be caused by an acquired bactericidal defect of macrophages. Malakoplakia is associated with chronic infections and immunosuppression. Although it occurs mainly in the urinary tract, it has already been reported in almost every organ system. The isolation of bacteria, especially Escherichia coli, is common in malakoplakia patients. Here, we present a case of primary cutaneous malakoplakia in a kidney transplant recipient who had been taking prednisone, tacrolimus, and mycophenolate. Culture of a lesion grew Burkholderia cepacia complex. Treatment with high doses of trimethoprim-sulfamethoxazole was successful. We also present a systematic review of the literature, identifying 4 previously reported cases of malakoplakia after renal transplantation under similar immunosuppressive therapy, most occurring in the urinary tract or perineum and following benign courses to cure. Data in the literature suggest that malakoplakia has become even rarer since changes were made in the immunosuppressive therapy employed after kidney transplantation.
引用
收藏
页码:E137 / E141
页数:5
相关论文
共 19 条
  • [1] MALAKOPLAKIA - EVIDENCE FOR MONOCYTE LYSOSOMAL ABNORMALITY CORRECTABLE BY CHOLINERGIC AGONIST INVITRO AND INVIVO
    ABDOU, NI
    NAPOMBEJARA, C
    SAGAWA, A
    RAGLAND, C
    STECHSCHULTE, DJ
    NILSSON, U
    GOURLEY, W
    WATANABE, I
    LINDSEY, NJ
    ALLEN, MS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (26) : 1413 - 1419
  • [2] Immunosuppressive drugs, the first 50 years and a glance forward
    Allison, AC
    [J]. IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 63 - 83
  • [3] Augusto J-F, 2008, NEPHROL DIAL TRANSPL, V5, P340
  • [4] BIGGAR WD, 1985, AM J PATHOL, V119, P5
  • [5] MALAKOPLAKIA OF THE LUNG - A REPORT OF 2 CASES
    COLBY, TV
    HUNT, S
    PELZMANN, K
    CARRINGTON, CB
    [J]. RESPIRATION, 1980, 39 (05) : 295 - 299
  • [6] Immunosuppressive drugs for kidney transplantation
    Halloran, PF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) : 2715 - 2729
  • [7] A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients
    Kobashigawa, J
    Miller, L
    Renlund, D
    Mentzer, R
    Alderman, E
    Bourge, R
    Costanzo, M
    Eisen, H
    Dureau, G
    Ratkovec, R
    Hummel, M
    Ipe, D
    Johnson, J
    Keogh, A
    Mamelok, R
    Mancini, D
    Smart, F
    Valantine, H
    [J]. TRANSPLANTATION, 1998, 66 (04) : 507 - 515
  • [8] Kohl SK, 2008, ARCH PATHOL LAB MED, V132, P113, DOI 10.1043/1543-2165(2008)132[113:CM]2.0.CO
  • [9] 2
  • [10] MALAKOPLAKIA
    MCCLURE, J
    [J]. JOURNAL OF PATHOLOGY, 1983, 140 (04) : 275 - 330